Cellebrite Endpoint Inspector Empowers Organizations with Remote Collection of Workplace Applications
Cellebrite now offers a competitive differentiator by offering the ability to collect remote mobile data, remote computer data, and cloud application data in a unified platform
PETAH TIKVA, ISRAEL and TYSONS CORNER, VA, November 16, 2022 – Cellebrite DI Ltd. (Nasdaq: CLBT), a global leader in Digital Intelligence (DI) solutions for the public and private sectors, today announced the launch of the cloud workplace app collection, a new Cellebrite Endpoint Inspector capability aimed at improving organizations’ investigation and eDiscovery capabilities by enabling them to collect remote mobile and computer data and cloud workplace application data in a unified platform.
The addition of the cloud workplace app collection to Cellebrite Endpoint Inspector should help reduce the time and cost associated with the collection of data from applications such as Office365, Google Workspace, Slack, and Box by allowing examiners to initiate multiple collections for custodians from the largest sources of employee work-related data. With our unified collection capability, and now adding cloud workplace app collection to Endpoint Inspector, customers will be able to have one tool for all their collection sources.
The cloud workplace app collection aims at enabling examiners to research and consolidate data, build a comprehensive picture, surface actionable insights, and uncover the truth. Additionally, the cloud workplace app collection uses smart collection capabilities to gather only necessary data from workplace applications while ensuring data security and privacy are protected at each step of the process.
Ken Basore, Enterprise Solutions General Manager at Cellebrite, said: “In today’s world, it is imperative that organizations in every industry and of every size can access employee work-related data in a secure and efficient way. Cloud workplace app collection is transforming how organizations collect data associated with corporate investigations and the eDiscovery process. We are proud to be the only company that offers a unified platform for remote mobile and computer collection and now from the most widely used cloud workplace applications – with our revolutionary capability, companies across the private sector can boost efficiencies while maintaining data security.”
For more information about workplace cloud app collection and Cellebrite Endpoint Inspector, please visit here.
Cellebrite’s (Nasdaq: CLBT) mission is to enable its customers to protect and save lives, accelerate justice, and preserve privacy in communities around the world. We are a global leader in Digital Intelligence solutions for the public and private sectors, empowering organizations in mastering the complexities of legally sanctioned digital investigations by streamlining intelligence processes. Trusted by thousands of leading agencies and companies worldwide, Cellebrite’s Digital Intelligence platform and solutions transform how customers collect, review, analyze and manage data in legally sanctioned investigations. To learn more visit us at www.cellebrite.com, https://investors.cellebrite.com, or follow us on Twitter at @Cellebrite_UFED.
Caution Regarding Forward-Looking Statements
This document includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements may be identified by the use of words such as “forecast,” “intend,” “seek,” “target,” “anticipate,” “will,” “appear,” “approximate,” “foresee,” “might,” “possible,” “potential,” “believe,” “could,” “predict,” “should,” “continue,” “expect,” “estimate,” “may,” “plan,” “outlook,” “future” and “project” and other similar expressions that predict, project or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements include estimated financial information. Such forward-looking statements with respect to revenues, earnings, performance, strategies, prospects, and other aspects of Cellebrite’s business are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual results or outcomes to differ materially from those indicated by such forward-looking statements. These factors include, but are not limited to: Cellebrite’s ability to keep pace with technological advances and evolving industry standards; Cellebrite’s material dependence on the acceptance of its solutions by law enforcement and government agencies; real or perceived errors, failures, defects or bugs in Cellebrite’s DI solutions; Cellebrite’s failure to maintain the productivity of sales and marketing personnel, including relating to hiring, integrating and retaining personnel; uncertainties regarding the impact of macroeconomic and/or global conditions, including COVID-19 and military actions involving Russia and Ukraine; intense competition in all of Cellebrite’s markets; the inadvertent or deliberate misuse of Cellebrite’s solutions; political and reputational factors related to Cellebrite’s business or operations; risks relating to estimates of market opportunity and forecasts of market growth; Cellebrite’s ability to properly manage its growth; risks associated with Cellebrite’s credit facilities and liquidity; Cellebrite’s reliance on third-party suppliers for certain components, products, or services; challenges associated with large transactions and long sales cycle; risks that Cellebrite’s customers may fail to honor contractual or payment obligations; risks associated with a significant amount of Cellebrite’s business coming from government customers around the world; risks related to Cellebrite’s intellectual property; security vulnerabilities or defects, including cyber-attacks, information technology system breaches, failures or disruptions; the mishandling or perceived mishandling of sensitive or confidential information; the complex and changing regulatory environments relating to Cellebrite’s operations and solutions; the regulatory constraints to which we are subject; risks associated with different corporate governance requirements applicable to Israeli companies and risks associated with being a foreign private issuer and an emerging growth company; market volatility in the price of Cellebrite’s shares; changing tax laws and regulations; risks associated with joint, ventures, partnerships and strategic initiatives; risks associated with Cellebrite’s significant international operations; risks associated with Cellebrite’s failure to comply with anti-corruption, trade compliance, anti-money-laundering and economic sanctions laws and regulations; risks relating to the adequacy of Cellebrite’s existing systems, processes, policies, procedures, internal controls and personnel for Cellebrite’s current and future operations and reporting needs; and other factors, risks and uncertainties set forth in the section titled “Risk Factors” in Cellebrite’s annual report on Form 20-F filed with the SEC on March 29, 2022,as amended on April 14, 2022 and in other documents filed by Cellebrite with the U.S. Securities and Exchange Commission (“SEC”), which are available free of charge at www.sec.gov. You are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, in this communication or elsewhere. Cellebrite undertakes no obligation to update its forward-looking statements, whether as a result of new information, future developments or otherwise, should circumstances change, except as otherwise required by securities and other applicable laws.
Public Relations and Corporate Communications Director